EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA

Description

The goal of this clinical trial is to learn how a group resistance training plan can improve body mobility and strength in female breast cancer patients who have completed their breast cancer treatment. The main questions it aims to answer are: * Is resistance training feasible following breast cancer treatment * Can it improve the body's mobility and strength lost as a result of the breast cancer treatment * can it improve the body's composition (for example muscle mass) * can resistance training increase one's activity level and help prevent weight gain, perhaps, lowering the risk of cancer recurrence. Participants will attend a group resistance training exercise group program, 3-4 times per week, under close supervision with monitoring a participant's ability to safely and effectively complete the program. The exercises include: lunges, squats and dead lifts.

Conditions

Breast Cancer Female

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to learn how a group resistance training plan can improve body mobility and strength in female breast cancer patients who have completed their breast cancer treatment. The main questions it aims to answer are: * Is resistance training feasible following breast cancer treatment * Can it improve the body's mobility and strength lost as a result of the breast cancer treatment * can it improve the body's composition (for example muscle mass) * can resistance training increase one's activity level and help prevent weight gain, perhaps, lowering the risk of cancer recurrence. Participants will attend a group resistance training exercise group program, 3-4 times per week, under close supervision with monitoring a participant's ability to safely and effectively complete the program. The exercises include: lunges, squats and dead lifts.

Prospective Study of an EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast Cancer

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA

Condition
Breast Cancer Female
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States, 15212

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 20-89 years
  • 2. Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
  • 3. Women must have undergone breast conservation therapy with no neoadjuvant or adjuvant chemotherapy (adjuvant endocrine therapy is permitted)
  • 4. Participants must have abstained from smoking for at least 12 months
  • 5. Women of child-bearing potential must have had a pregnancy test prior to initiation of radiation therapy (standard protocol for radiation therapy); verbally confirm lack of pregnancy prior to enrollment; and, consent to use adequate contraception during the course of the study.
  • 6. Participants must be determined capable of engaging in resistance training.
  • 7. Participants must have a schedule amenable to three prescheduled workout sessions per week, scheduled during the day.
  • 8. Participants must complete a Functional Mobility Screen (FMS) and be determined safe to engage in the workout regimen by the study exercise personnel.
  • 9. Participants must be determined capable of engaging in group resistance training sessions by exercise personnel and/or study PI
  • 10. Participants must be able to get down and up from the ground and squat their body weight.
  • 1. Any treatment with chemotherapy for breast cancer
  • 2. Inability to get and down off the ground or squat body weight
  • 3. Inability to safely engage in group sessions
  • 4. Severe arthritic, joint, cardiovascular, or musculoskeletal condition

Ages Eligible for Study

20 Years to 89 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Colin Champ, MD,

Colin Champ, MD, PRINCIPAL_INVESTIGATOR, AGH Radiation Oncology

Study Record Dates

2023-08